These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9. Jin Q; He W; Chen L; Yang Y; Shi K; You Z Exp Ther Med; 2018 Sep; 16(3):1663-1670. PubMed ID: 30186385 [TBL] [Abstract][Full Text] [Related]
67. miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways [Retraction]. Onco Targets Ther; 2024; 17():305-306. PubMed ID: 38617089 [TBL] [Abstract][Full Text] [Related]
68. lncRNA LSINCT5 Regulates miR-20a-5p/XIAP to Inhibit the Growth and Metastasis of Osteosarcoma Cells [Retraction]. Onco Targets Ther; 2020; 13():12197. PubMed ID: 33273824 [TBL] [Abstract][Full Text] [Related]
69. ZNRD1-AS1 knockdown alleviates malignant phenotype of retinoblastoma through miR-128-3p/BMI1 axis. Yang G; Zeng C; Liu Y; Li D; Cui J Am J Transl Res; 2021; 13(6):5866-5879. PubMed ID: 34306331 [TBL] [Abstract][Full Text] [Related]
70. The Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Retraction]. Onco Targets Ther; 2023; 16():483-484. PubMed ID: 37396312 [TBL] [Abstract][Full Text] [Related]
71. miR-182 Promotes Tumor Growth and Increases Chemoresistance of Human Anaplastic Thyroid Cancer by Targeting Tripartite Motif 8 [Retraction]. Onco Targets Ther; 2024; 17():101-102. PubMed ID: 38371879 [TBL] [Abstract][Full Text] [Related]
72. Hsa_circ_0000527 Downregulation Suppresses the Development of Retinoblastoma by Modulating the miR-27a-3p/HDAC9 Pathway. Zuo X; Fu C; Xie J; Wang X; Yan Z Curr Eye Res; 2022 Jan; 47(1):115-126. PubMed ID: 34823425 [TBL] [Abstract][Full Text] [Related]
73. miR-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA [Retraction]. Onco Targets Ther; 2023; 16():261-262. PubMed ID: 37065775 [TBL] [Abstract][Full Text] [Related]
74. The Important Tumor Suppressor Role of Onco Targets Ther; 2023; 16():423-424. PubMed ID: 37359352 [TBL] [Abstract][Full Text] [Related]
75. lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis [Retraction]. Onco Targets Ther; 2022; 15():133-134. PubMed ID: 35115788 [TBL] [Abstract][Full Text] [Related]
76. Long non-coding RNA XIST confers aggressive progression via miR-361-3p/STX17 in retinoblastoma cells. Yang LL; Li Q; Zhang X; Cao T Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10433-10444. PubMed ID: 33155266 [TBL] [Abstract][Full Text] [Related]
77. miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction]. Cancer Manag Res; 2020; 12():12581. PubMed ID: 33324102 [TBL] [Abstract][Full Text] [Related]
78. lncRNA KCNQ1OT1 promotes the proliferation, migration and invasion of retinoblastoma cells by upregulating HIF-1α via sponging miR-153-3p. Wang Y; Wang J; Hao H; Luo X J Investig Med; 2020 Dec; 68(8):1349-1356. PubMed ID: 33051357 [TBL] [Abstract][Full Text] [Related]
79. Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression [Retraction]. Onco Targets Ther; 2021; 14():4743-4744. PubMed ID: 34526780 [TBL] [Abstract][Full Text] [Related]
80. MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-Mediated PI3K/Akt Signaling Pathway [Retraction]. Onco Targets Ther; 2021; 14():1859. PubMed ID: 33732003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]